Phase II&#160;study of bemnifosbuvir in high-risk participants in a hospital setting with moderate COVID-19.

bemnifosbuvir (AT-527) - Atea Pharma

http://www.ncbi.nlm.nih.gov/pubmed/38051993

Arantxa Horga; Bruce Belanger; Daniel R Kuritzkes; Janet Hammond; John J Kowalczyk; Kai Lin; Keith Pietropaolo; Kristen Perkins

Dec 6, 2023